経粘膜ドラッグデリバリーデバイスの世界市場レポート 2025年

経粘膜ドラッグデリバリーデバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.2％で、782億1,000万米ドルに成長します。予測期間の成長は、スマートドラッグデリバリーシステムの開発、慢性疾患の増加、個別化医療への注目の高まり、投薬ニーズの高い高齢化、意識の高まりなどに起因すると考えられます。予測期間における主な動向としては、治療用途の拡大、個別化医療に向けたドラッグデリバリーデバイスのカスタマイズ、規制当局の承認とガイドライン、新興市場、環境に優しいデバイス、革新的な製剤などが挙げられます。

慢性疾患の有病率の増加が、今後数年間の経粘膜ドラッグデリバリーデバイス市場の成長を牽引すると予想されます。慢性疾患は、一般的に徐々に発症し長期にわたって持続する疾患であり、多くの場合、症状のコントロールや合併症の予防のために継続的な医学的管理が必要となります。慢性疾患の増加は、ライフスタイルの選択、人口の高齢化、環境の影響、ヘルスケアシステム内の課題、都市化などの要因に起因しています。経粘膜ドラッグデリバリーデバイスは、コントロールされた効率的な薬物送達を提供し、治療レベルの持続を保証して症状を管理し、患者のアドヒアランスを高めることにより、慢性疾患の管理に使用されます。例えば、2023年8月、米国を拠点とする非営利団体Leukemia &Lymphoma Society（LLS）の報告によると、米国では約3分に1人の割合で白血病、リンパ腫、骨髄腫と診断されています。2023年には、推定18万4,720人が診断されると予想され、その年の新規がん患者数195万8,310人の9.4％を占める。したがって、慢性疾患の有病率の上昇が経粘膜ドラッグデリバリーデバイス市場の成長を促進しています。

経粘膜ドラッグデリバリーデバイス分野の主要企業は、独自の経皮パッチデリバリープラットフォームのような革新的なソリューションを積極的に追求しており、これらは薬物の吸収を改善し、患者のコンプライアンスを高め、利便性を提供するように設計されています。これらのプラットフォームは、各社が保有する特殊技術を利用して皮膚から薬剤を投与し、放出制御と治療結果の最適化を実現します。例えば、米国を拠点とするバイオテクノロジー企業Starton Therapeutics Inc.は2024年1月、新規の独自経皮パッチ送達プラットフォームであるSTARSILONを発表しました。このプラットフォームは、製剤化が困難な有効医薬品成分（API）を長期間にわたって送達するよう特別に設計されており、それによって経皮ドラッグデリバリーの選択肢を広げ、徐放メカニズムによって治療効果を高める。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経粘膜ドラッグデリバリーデバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の経粘膜ドラッグデリバリーデバイス市場：成長率分析
• 世界の経粘膜ドラッグデリバリーデバイス市場の実績：規模と成長, 2019-2024
• 世界の経粘膜ドラッグデリバリーデバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界経粘膜ドラッグデリバリーデバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経粘膜ドラッグデリバリーデバイス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 受動的な経皮ドラッグデリバリー
• 能動経皮ドラッグデリバリー
• 世界の経粘膜ドラッグデリバリーデバイス市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バッカル錠
• 経口スプレー
• 舌下フィルムとウエハース
• ゲル
• 薬用菓子類
• その他の薬物の種類
• 世界の経粘膜ドラッグデリバリーデバイス市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 依存症治療
• ホルモン療法
• その他の適応症
• 世界の経粘膜ドラッグデリバリーデバイス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術研究機関
• 製薬およびバイオテクノロジー企業
• 診断検査室
• 病院
• 世界の経粘膜ドラッグデリバリーデバイス市場受動経皮ドラッグデリバリーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 貯水池システム
• マトリックスシステム
• マイクロニードルシステム
• 感圧接着システム
• 世界の経粘膜ドラッグデリバリーデバイス市場、タイプ別アクティブ経皮ドラッグデリバリーのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• イオントフォレシス
• ソノフォレシス
• エレクトロポレーション
• 熱アブレーション
• マイクロポレーション

第7章 地域別・国別分析

• 世界の経粘膜ドラッグデリバリーデバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経粘膜ドラッグデリバリーデバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経粘膜ドラッグデリバリーデバイス市場：競合情勢
• 経粘膜ドラッグデリバリーデバイス市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Becton Dickinson and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Catalent Inc.
• AptarGroup
• Glenmark Pharmaceuticals Limited
• Stevanato Group S.p.A
• Lifevision Healthcare Private Limited
• Noven Pharmaceuticals
• SAVA Healthcare Limited
• Antares Pharma Inc.
• Kaizen Pharmaceuticals Pvt. Ltd.
• Lucky Pharma Pvt. Ltd.
• Maya Biotech Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経粘膜ドラッグデリバリーデバイス市場2029：新たな機会を提供する国
• 経粘膜ドラッグデリバリーデバイス市場2029：新たな機会を提供するセグメント
• 経粘膜ドラッグデリバリーデバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Transmucosal drug delivery devices are medical instruments designed to administer drugs through mucous membranes, such as those found in the mouth, nose, or rectum, allowing for rapid absorption into the bloodstream. These devices are particularly useful for delivering medications that are poorly absorbed by the gastrointestinal tract or require swift onset of action, such as pain relief or hormone therapy. Their primary function is to circumvent the digestive system, offering a direct and efficient route for drug delivery.

The two main categories of transmucosal drug delivery devices are passive transmucosal drug delivery and active transmucosal drug delivery. Passive transmucosal drug delivery involves the absorption of drugs through mucous membranes without external energy or active transport mechanisms. Various types of products include buccal tablets, oral sprays, sublingual films, wafers, gels, medicated confectionery, among others, used for treating conditions such as pain management, addiction, and hormonal therapies. End users include academic and research institutions, pharmaceutical and biotechnology firms, diagnostic laboratories, and hospitals.

The transmucosal drug delivery devices research report is one of a series of new reports from The Business Research Company that provides transmucosal drug delivery devices market statistics, including the transmucosal drug delivery devices industry's global market size, regional shares, competitors with a transmucosal drug delivery devices market share, detailed transmucosal drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the transmucosal drug delivery devices industry. This transmucosal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $50.24 billion in 2024 to $55.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins.

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $78.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations.

The increasing prevalence of chronic diseases is expected to drive the growth of the transmucosal drug delivery devices market in the coming years. Chronic diseases are long-lasting conditions that typically develop gradually and persist over time, often requiring ongoing medical management to control symptoms and prevent complications. The rise in chronic diseases can be attributed to factors such as lifestyle choices, aging populations, environmental influences, challenges within healthcare systems, and urbanization. Transmucosal drug delivery devices are employed in managing chronic diseases by providing controlled and efficient medication delivery, ensuring sustained therapeutic levels to manage symptoms and enhance patient adherence. For example, in August 2023, a report from the Leukemia & Lymphoma Society (LLS), a US-based nonprofit organization, indicated that in the US, a person is diagnosed with leukemia, lymphoma, or myeloma approximately every three minutes. In 2023, an estimated 184,720 individuals were expected to be diagnosed, accounting for 9.4% of the projected 1,958,310 new cancer cases for the year. Therefore, the rising prevalence of chronic diseases is fueling the growth of the transmucosal drug delivery devices market.

Leading companies in the transmucosal drug delivery devices sector are actively pursuing innovative solutions such as proprietary transdermal patch delivery platforms, which are designed to improve drug absorption, enhance patient compliance, and offer convenience. These platforms utilize specialized technologies owned by companies to administer medications through the skin, ensuring controlled release and optimized therapeutic outcomes. For example, in January 2024, Starton Therapeutics Inc., a US-based biotechnology firm, introduced STARSILON, a novel proprietary transdermal patch delivery platform. This platform is specifically designed to deliver difficult-to-formulate active pharmaceutical ingredients (APIs) over an extended period, thereby expanding the options for transdermal drug delivery and enhancing therapeutic efficacy through sustained release mechanisms.

In April 2023, Difgen Pharmaceuticals, an India-based pharmaceutical company, acquired Aveva Drug Delivery Services for an undisclosed sum. This strategic acquisition is intended to bolster Difgen Pharmaceuticals' drug delivery capabilities and incorporate advanced technologies into its pharmaceutical product portfolio. Aveva Drug Delivery Services, based in the US, specializes in manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transmucosal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transmucosal drug delivery devices market consists of sales of sublingual sprays, nasal drops, rectal suppositories, and sublingual tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transmucosal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transmucosal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transmucosal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transmucosal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Passive Transdermal Drug Delivery; Active Transdermal Drug Delivery
• 2) By Drug Type: Buccal Tablets; Oral Sprays; Sublingual Films And Wafers; Gels; Medicated Confectionery; Other Drug Types
• 3) By Indication: Pain Management; Addiction Treatment; Hormonal Therapies; Others Indications
• 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Hospitals
• Subsegments:
• 1) By Passive Transdermal Drug Delivery: Reservoir Systems; Matrix Systems; Micro-Needle Systems; Pressure-Sensitive Adhesive Systems
• 2) By Active Transdermal Drug Delivery: Iontophoresis; Sonophoresis; Electroporation; Thermal Ablation; Microporation
• Companies Mentioned: Johnson & Johnson; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transmucosal Drug Delivery Devices Market Characteristics

3. Transmucosal Drug Delivery Devices Market Trends And Strategies

4. Transmucosal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Transmucosal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Transmucosal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Transmucosal Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Transmucosal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Transmucosal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Transmucosal Drug Delivery Devices Total Addressable Market (TAM)

6. Transmucosal Drug Delivery Devices Market Segmentation

• 6.1. Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Passive Transdermal Drug Delivery
• Active Transdermal Drug Delivery
• 6.2. Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Tablets
• Oral Sprays
• Sublingual Films And Wafers
• Gels
• Medicated Confectionery
• Other Drug Types
• 6.3. Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Addiction Treatment
• Hormonal Therapies
• Other Indications
• 6.4. Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Diagnostic Laboratories
• Hospitals
• 6.5. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Passive Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reservoir Systems
• Matrix Systems
• Micro-Needle Systems
• Pressure-Sensitive Adhesive Systems
• 6.6. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Active Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iontophoresis
• Sonophoresis
• Electroporation
• Thermal Ablation
• Microporation

7. Transmucosal Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transmucosal Drug Delivery Devices Market

• 8.1. Asia-Pacific Transmucosal Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transmucosal Drug Delivery Devices Market

• 9.1. China Transmucosal Drug Delivery Devices Market Overview
• 9.2. China Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transmucosal Drug Delivery Devices Market

• 10.1. India Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transmucosal Drug Delivery Devices Market

• 11.1. Japan Transmucosal Drug Delivery Devices Market Overview
• 11.2. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transmucosal Drug Delivery Devices Market

• 12.1. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transmucosal Drug Delivery Devices Market

• 13.1. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transmucosal Drug Delivery Devices Market

• 14.1. South Korea Transmucosal Drug Delivery Devices Market Overview
• 14.2. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transmucosal Drug Delivery Devices Market

• 15.1. Western Europe Transmucosal Drug Delivery Devices Market Overview
• 15.2. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transmucosal Drug Delivery Devices Market

• 16.1. UK Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transmucosal Drug Delivery Devices Market

• 17.1. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transmucosal Drug Delivery Devices Market

• 18.1. France Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transmucosal Drug Delivery Devices Market

• 19.1. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transmucosal Drug Delivery Devices Market

• 20.1. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transmucosal Drug Delivery Devices Market

• 21.1. Eastern Europe Transmucosal Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transmucosal Drug Delivery Devices Market

• 22.1. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transmucosal Drug Delivery Devices Market

• 23.1. North America Transmucosal Drug Delivery Devices Market Overview
• 23.2. North America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transmucosal Drug Delivery Devices Market

• 24.1. USA Transmucosal Drug Delivery Devices Market Overview
• 24.2. USA Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transmucosal Drug Delivery Devices Market

• 25.1. Canada Transmucosal Drug Delivery Devices Market Overview
• 25.2. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transmucosal Drug Delivery Devices Market

• 26.1. South America Transmucosal Drug Delivery Devices Market Overview
• 26.2. South America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transmucosal Drug Delivery Devices Market

• 27.1. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transmucosal Drug Delivery Devices Market

• 28.1. Middle East Transmucosal Drug Delivery Devices Market Overview
• 28.2. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transmucosal Drug Delivery Devices Market

• 29.1. Africa Transmucosal Drug Delivery Devices Market Overview
• 29.2. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transmucosal Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Transmucosal Drug Delivery Devices Market Competitive Landscape
• 30.2. Transmucosal Drug Delivery Devices Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Transmucosal Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Becton Dickinson and Company
• 31.3. Viatris Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Catalent Inc.
• 31.6. AptarGroup
• 31.7. Glenmark Pharmaceuticals Limited
• 31.8. Stevanato Group S.p.A
• 31.9. Lifevision Healthcare Private Limited
• 31.10. Noven Pharmaceuticals
• 31.11. SAVA Healthcare Limited
• 31.12. Antares Pharma Inc.
• 31.13. Kaizen Pharmaceuticals Pvt. Ltd.
• 31.14. Lucky Pharma Pvt. Ltd.
• 31.15. Maya Biotech Pvt. Ltd.

32. Global Transmucosal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transmucosal Drug Delivery Devices Market

34. Recent Developments In The Transmucosal Drug Delivery Devices Market

35. Transmucosal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Transmucosal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Transmucosal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Transmucosal Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer